Stefano Marino, a former head of the European Medicines Agency’s (EMA) legal department, has joined DLA Piper as a senior consultant.
Mr. Marino, who will not be located in Dublin, brings with him a wealth of experience from his 25 years in industry and nearly 11 years with the EMA, including a thorough understanding of EU pharmaceutical law and familiarity with Union practice and processes.
He oversaw the legal department at the EMA and supported core business colleagues on pharmaceutical law and regulatory matters. He also oversaw the agency’s litigation strategy in EU courts and regularly collaborated with other agencies’ legal experts on matters pertaining to artificial intelligence, insurance, and personal data protection.
Before coming to work at EMA, Mr. Marino was general counsel of the Menarini Group for eight years, general counsel at Sigma-Tau (now Alfasigma) for fifteen years, and nearly two more years spent in the petrochemical industry.
In addition, he served as the chair of the EFPIA’s trademark group for eight years and as a member of the committee on intellectual property policy for fifteen years. “Ireland is home to all but one of the world’s 25 largest biotech and pharma companies, so the appointment of Stefano to the firm as senior consultant is significant,” said Aoife Murphy, a partner at DLA Piper Ireland, in response to the news.
“Our ability to solve complex regulatory challenges for our clients, not only corporates but also industry associations and regulatory authorities as they seek counsel on the changing regulatory framework governing medicinal products in the EU, will undoubtedly be enhanced by Stefano’s knowledge, prestige, and recognition in the European and international life sciences market.”His hiring is a significant step toward our goal of becoming a pre-eminent bio sciences regulatory practice in the EU and beyond the world.
Read More : https://thecioleaders.com/